Common antimicrobials help patients recover from MRSA abscesses

Common antimicrobials help patients recover from MRSA abscesses
MRSA bacteria, like those shown here, are present both in hospitals and the environment at large, and can cause difficult-to-treat skin infections. Credit: NIAID

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are resistant to multiple antibiotics and commonly cause skin infections that can lead to more serious or life-threatening infection in other parts of the body. In new findings published in The New England Journal of Medicine, researchers found that two common, inexpensive antimicrobials can help patients heal from MRSA skin abscesses. The findings suggest that current treatment options for MRSA still have a role, even as scientists continue to search for new antimicrobial products. The research was funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH).

The study was conducted at hospitals across the United States and involved 796 children and adults with small, uncomplicated abscesses. All patients had their abscesses opened and drained as part of standard MRSA treatment. The patients were then sorted into three groups, each of which received a different, ten-day oral treatment regimen. One group received clindamycin, a second group received trimethoprim-sulfamethoxazole (TMP-SMX), and the third group received placebo.

The group treated with clindamycin had an 81.7 percent cure rate, and the group that received TMP-SMX had an 84.6 percent cure rate. The placebo had a 62.9 percent cure rate. According to the researchers, the findings contradict a commonly held belief that antimicrobial treatment is little better than doing nothing for MRSA skin infections. It corroborates the findings of another NIAID-funded study demonstrating that TMP-SMX treatment resulted in better clinical outcomes than placebo for MRSA skin abscesses, and also upholds other findings that both clindamycin and TMP-SMX are equally beneficial in treating MRSA skin infections.

The researchers note, however, that the side effects of clindamycin and TMP-SMX (including nausea, diarrhea, and possible new Clostridium difficile infections) can be severe. In addition, some strains of Staphylococcus are resistant to . The authors recommend that healthcare providers weigh the risks but not dismiss these antimicrobials out of hand as viable treatment options for MRSA skin abscesses.


Explore further

Comparison of antibiotic treatments for cellulitis

More information: Robert S. Daum et al, A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses, New England Journal of Medicine (2017). DOI: 10.1056/NEJMoa1607033
Journal information: New England Journal of Medicine

Citation: Common antimicrobials help patients recover from MRSA abscesses (2017, June 29) retrieved 18 October 2019 from https://medicalxpress.com/news/2017-06-common-antimicrobials-patients-recover-mrsa.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
45 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more